Allegion (NYSE:ALLE) Price Target Lowered to $176.00 at Barclays

Allegion (NYSE:ALLE) had its target price reduced by equities researchers at Barclays from $180.00 to $176.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the scientific and technical instruments company’s stock. Barclays‘s target price points to a potential upside of 8.42% from the company’s previous close.

Several other equities analysts have also commented on the stock. Wells Fargo & Company restated a “positive” rating on shares of Allegion in a report on Tuesday, December 16th. JPMorgan Chase & Co. cut their price objective on Allegion from $190.00 to $180.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Allegion in a research report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $175.00.

Allegion Price Performance

ALLE stock opened at $162.34 on Monday. Allegion has a 52-week low of $116.57 and a 52-week high of $183.11. The business has a fifty day moving average of $165.46 and a two-hundred day moving average of $168.13. The stock has a market cap of $13.98 billion, a price-to-earnings ratio of 21.82, a price-to-earnings-growth ratio of 3.50 and a beta of 1.03. The company has a quick ratio of 1.16, a current ratio of 1.84 and a debt-to-equity ratio of 0.96.

Allegion (NYSE:ALLE) last released its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $1.94 earnings per share for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.07). The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.04 billion. Allegion had a return on equity of 38.06% and a net margin of 15.83%.The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.86 earnings per share. Allegion has set its FY 2026 guidance at 8.700-8.900 EPS. As a group, research analysts anticipate that Allegion will post 7.77 earnings per share for the current year.

Insider Transactions at Allegion

In other news, Director Steven Mizell sold 1,000 shares of Allegion stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $161.51, for a total value of $161,510.00. Following the completion of the transaction, the director owned 4,915 shares in the company, valued at approximately $793,821.65. This trade represents a 16.91% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.23% of the stock is owned by corporate insiders.

Institutional Trading of Allegion

Several hedge funds have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Allegion by 7.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,592 shares of the scientific and technical instruments company’s stock worth $1,251,000 after acquiring an additional 626 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Allegion by 35.3% in the 1st quarter. NewEdge Advisors LLC now owns 3,272 shares of the scientific and technical instruments company’s stock valued at $427,000 after purchasing an additional 854 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Allegion by 44.2% in the 1st quarter. Jones Financial Companies Lllp now owns 1,629 shares of the scientific and technical instruments company’s stock valued at $213,000 after purchasing an additional 499 shares in the last quarter. Empowered Funds LLC lifted its position in shares of Allegion by 13.0% during the 1st quarter. Empowered Funds LLC now owns 5,673 shares of the scientific and technical instruments company’s stock worth $740,000 after purchasing an additional 651 shares during the last quarter. Finally, Focus Partners Wealth grew its stake in shares of Allegion by 204.5% during the first quarter. Focus Partners Wealth now owns 7,186 shares of the scientific and technical instruments company’s stock worth $937,000 after purchasing an additional 4,826 shares in the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.

Allegion Company Profile

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.